HAYA Therapeutics, based in Lausanne and San Diego, pioneers antisense RNA therapeutics for fibrotic diseases. The Senior CMC leader will drive the global CMC strategy, oversee outsourcing CDMOs, and ensure timely, compliant regulatory submissions across clinical stages.
Responsibilities include optimizing oligonucleotide manufacturing, developing analytical methods, and collaborating with QA and regulatory teams to enable trial material readiness across global programs.
#J-18808-LjbffrGlobal CMC Director, Therapeutic Oligonucleotides in san diego at Unknown Company
This position is listed as full time and onsite.